Ignite Creation Date:
2024-05-06 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 12:50 PM
Study NCT ID:
NCT03613636
Status:
COMPLETED
Last Update Posted:
2024-02-22
First Post:
2018-07-06
Brief Title:
Evaluation of Pathogenesis and Diagnosis of Mycoplasma Pneumoniae Community-acquired Pneumonia CAP
Sponsor:
University Childrens Hospital Zurich
Organization:
University Childrens Hospital Zurich
Study Overview
Official Title:
The Role of Adaptive Immune Responses to Mycoplasma Pneumoniae in Pathogenesis and Diagnosis of Community-acquired Pneumonia CAP in Children an Observational Single-center Study myCAP Study
Status:
COMPLETED
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
myCAP
Brief Summary:
To investigate the Mycoplasma pneumoniae-specific circulating antibody-secreting cell ASC response and Mycoplasma pneumoniae-specific interferon INF-γ-secreting T cell response along with polymerase chain reaction PCR and serology in a cohort of children with community-acquired pneumonia CAP and controls
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None